Interlinked AB Advances Healthcare Solutions with ReLink®
Interlinked AB has achieved a significant milestone by gaining CE-MDR approval for its medical device platform ReLink®. This innovative solution is designed as a dual-use system, effectively bridging both civilian and military healthcare needs, particularly in medical preparedness and field hospital settings.
The value of ReLink® is already evident from its recurring sales and clinical application in hospitals across various countries in Europe. This groundbreaking device is the only breakaway connector that maintains a closed state before, during, and after disconnection, which ultimately aids in reducing the risks of accidental catheter dislodgment—an expensive and common issue in IV therapy and drainage.
Due to its unique double-valve breakaway mechanism, ReLink® ensures that it remains closed upon separation. This crucial feature helps in preventing spillage, contamination, and harm related to patient care. With such advanced design, it is clear that ReLink® is setting a new standard in patient safety.
Katarina Hedbeck, CEO and co-founder of Interlinked AB, expressed her enthusiasm regarding this strategic development. She stated, "The ability of ReLink® to deliver exceptional safety and functionality in various healthcare contexts—including civilian facilities and emergency scenarios—illustrates the strength and versatility of our platform. Our goal is to enhance patient safety, whether treatment is administered in a leading university hospital or within a military deployment or disaster response situation. The demand is evident, and interest is rapidly increasing."
In environments where healthcare is delivered under pressure or with limited resources, such as field hospitals and emergency preparedness scenarios, ReLink® stands out as an effective solution. This medical device not only supports healthcare systems but also optimizes the time of clinical staff, thereby minimizing avoidable healthcare expenses.
Interlinked AB is now keen on initiating conversations with defense, civil protection, and humanitarian medical organizations, as they aspire to make ReLink® more accessible to areas that require it most urgently.
About Interlinked AB
Interlinked AB is a pioneering MedTech company from Sweden. With its CE-MDR approved medical device platform, the company is on a mission to enhance patient safety while improving clinical workflows and reducing healthcare expenditures. Interlinked is currently advancing into a new phase of international expansion, aiming to create global impact through its innovative solutions.
Interested in collaborating?
The company invites discussions with defense forces, emergency preparedness organizations, humanitarian medical agencies, and healthcare partners. These conversations also extend to potential investors and entities interested in participating in the ongoing growth of Interlinked AB.
Frequently Asked Questions
What is ReLink®?
ReLink® is a CE-MDR approved medical device platform developed by Interlinked AB that serves as a dual-use solution for civilian and military healthcare.
How does ReLink® enhance patient safety?
The device features a breakaway connector that remains closed at all times, minimizing the risk of accidental catheter dislodgment during IV therapy.
Who can benefit from ReLink®?
Healthcare professionals in civilian hospitals and military environments, particularly in emergency situations, can greatly benefit from ReLink®.
What are the goals of Interlinked AB?
Interlinked AB aims to improve patient safety, optimize clinical workflows, and reduce healthcare costs through its innovative medical devices.
How is Interlinked AB expanding its market presence?
The company is entering a phase of international expansion, focusing on outreach and partnerships with various organizations to maximize the application of ReLink®.
